Objectif The establishment of influential public and private public partnerships fostering true collaboration between big Pharma and universities for a non-profit end goal has opened the door for stronger interaction and integration. This structural change has come to stay and is slowly permeating other sectors in which the commercial return on investment is clear (Drug. Discov. Today, 2009, 14, 1003). This new paradigm is also creating opportunities for young scientists to experience and understand both industrial and academic points of view when it comes to the early discovery and pharmaceutical development of new drugs. A new generation of scientists trained under a public-private partnership will find itself in a privileged position in terms of employment opportunities. Moreover, the close ties arising from this interaction will improve the dialogue between Pharma and academia, resulting in faster implementation of relevant medicinal chemistry basic science discoveries into the Pharma pipeline and a better understanding within academia of the critical limiting factors behind falling productivity in the Pharma sector.In this context, neglected diseases research and development is opening important new avenues of collaboration between academia and industry. The scientific focus of this EID project will be on the design and synthesis of novel antituberculosis drugs. The fellows will have unique access to corporate HTS screening hits while being exposed to both industrial and academic med chem strategies and philosophies. These chemical efforts will be supported by the application of state of the art chemical biology tools for investigation of compound activity profiles. In particular, the new single cell microfluidic-microscopy system at the industrial partner´s site will allow for in depth study of the activities of the new compounds, while also providing a platform for investigating the gross modes of action of both novel and known antituberculars. Champ scientifique medical and health sciencesbasic medicinemedicinal chemistry Programme(s) FP7-PEOPLE - Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) Thème(s) FP7-PEOPLE-2012-ITN - Marie-Curie Action: "Initial Training Networks" Appel à propositions FP7-PEOPLE-2012-ITN Voir d’autres projets de cet appel Régime de financement MC-ITN - Networks for Initial Training (ITN) Coordinateur UNIVERSITEIT ANTWERPEN Contribution de l’UE € 348 137,90 Adresse PRINSSTRAAT 13 2000 Antwerpen Belgique Voir sur la carte Région Vlaams Gewest Prov. Antwerpen Arr. Antwerpen Type d’activité Higher or Secondary Education Establishments Contact administratif Anne Adams (Mrs.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée Participants (1) Trier par ordre alphabétique Trier par contribution de l’UE Tout développer Tout réduire GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL Espagne Contribution de l’UE € 341 972,74 Adresse C/ SEVERO OCHOA NUMERO 2 PARQUE TECNOLOGICO DE MAD 28760 TRES CANTOS MADRID Voir sur la carte Région Comunidad de Madrid Comunidad de Madrid Madrid Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Contact administratif Lluis Ballell (Dr.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée
